Mechanism of natural antioxidants regulating advanced glycosylation end products of Maillard reaction

被引:105
|
作者
Jia, Wei [1 ,2 ]
Guo, Aiai [1 ]
Zhang, Rong [1 ]
Shi, Lin [1 ]
机构
[1] Shaanxi Univ Sci & Technol, Sch Food & Biol Engn, Xian 710021, Peoples R China
[2] Shaanxi Res Inst Agr Prod Proc Technol, Xian 710021, Peoples R China
关键词
Maillard reaction; Advanced glycation end products; Formation mechanism; Reaction kinetics; Inhibition mechanism; ADVANCED GLYCATION ENDPRODUCTS; MODEL; FOODS; AGES; N-EPSILON-(CARBOXYMETHYL)LYSINE; INHIBITION; SYSTEMS; MEAT; RATS; RAW;
D O I
10.1016/j.foodchem.2022.134541
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
According to the investigation of Food and Drug Administration 2021, one hundred and twenty-six potentially harmful substances are produced by Maillard reaction. Discovery of advanced glycosylation end products (AGEs) of Maillard reaction has impacted public's understanding of the transformation mechanism of Maillard reaction and its impact on health. This review clarifies the reaction kinetics of N epsilon-(carboxymethyl) lysine, the repre-sentative substance of AGEs in food simulation system, and key nodes of forming AGEs. Inhibition mechanism of natural antioxidants is expounded from the aspects of biological activity, inhibition of protein glycosylation and its structure-activity relationship. Transformation mechanism is mainly to scavenge free radicals, capture active carbonyl compounds and protect protein glycosylation sites. Nutraceutical polyphenols can regulate the expression of RAEG, effectively promote KEAP1-Nrf2 pathway, inhibit MAPK and TGF-beta pathway. Inhibition mechanism and novel application in foods processing in the future should be further studied in future.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] MACROPHAGE SCAVENGER RECEPTOR MEDIATES THE ENDOCYTIC UPTAKE AND DEGRADATION OF ADVANCED GLYCATION END-PRODUCTS OF THE MAILLARD REACTION
    ARAKI, N
    HIGASHI, T
    MORI, T
    SHIBAYAMA, R
    KAWABE, Y
    KODAMA, T
    TAKAHASHI, K
    SHICHIRI, M
    HORIUCHI, S
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 230 (02): : 408 - 415
  • [32] IMMUNOCHEMICAL APPROACH TO CHARACTERIZE ADVANCED GLYCATION END-PRODUCTS OF THE MAILLARD REACTION - EVIDENCE FOR THE PRESENCE OF A COMMON STRUCTURE
    HORIUCHI, S
    ARAKI, N
    MORINO, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (12) : 7329 - 7332
  • [33] Advanced glycosylation end products in diabetic renal and vascular disease
    Bucala, R
    Vlassara, H
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (06) : 875 - 888
  • [34] IMMUNOCHEMICAL DETECTION OF ADVANCED GLYCOSYLATION END-PRODUCTS INVIVO
    MAKITA, Z
    VLASSARA, H
    CERAMI, A
    BUCALA, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (08) : 5133 - 5138
  • [35] Advanced glycosylation end products in peritoneal tissue with different solutions
    Dobbie, JW
    PERITONEAL DIALYSIS INTERNATIONAL, 1997, 17 : S27 - S30
  • [36] Pathogenic role of advanced glycosylation end products in diabetic nephropathy
    Lee, HB
    Cha, MK
    Song, KI
    Kim, JH
    Lee, EY
    Kim, SI
    Kim, J
    Yoo, MH
    KIDNEY INTERNATIONAL, 1997, : S60 - S65
  • [37] The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis
    Makita, Z
    Yanagisawa, K
    Kuwajima, S
    Bucala, R
    Vlassara, H
    Koike, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 31 - 33
  • [38] Serum levels of advanced glycosylation end products in diabetic nephropathy
    Kanauchi, M
    Nishioka, H
    Dohi, K
    NEPHRON, 2001, 89 (02): : 228 - 230
  • [39] ADVANCED GLYCOSYLATION END-PRODUCTS IN PATIENTS WITH DIABETIC NEPHROPATHY
    MAKITA, Z
    RADOFF, S
    RAYFIELD, EJ
    YANG, Z
    SKOLNIK, E
    DELANEY, V
    FRIEDMAN, EA
    CERAMI, A
    VLASSARA, H
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (12): : 836 - 842
  • [40] ADVANCED GLYCOSYLATION END-PRODUCTS IN THE MESENTERIC-ARTERY
    MACDONALD, E
    LEE, WK
    HEPBURN, S
    BELL, J
    SCOTT, PJW
    DOMINICZAK, MH
    CLINICAL CHEMISTRY, 1992, 38 (04) : 530 - 533